Rs. 14.00 per
10 s per pack
Most common adverse reactions (≥5% and at least twice placebo) are abnormal ejaculation, , asthenia, constipation, decreased appetite, diarrhea, dizziness, dry mouth, female genital disorder, impotence, infection, insomnia, libido decreased, male genital disorder, nausea, nervousness, somnolence, sweating, tremor, yawn.
It should not be used Concomitantly with monoamine oxidase inhibitors (MAOIs) or use within 14\ days of discontinuing a MAOI, with pimozide or thioridazine. It should also not to be used in patients with known hypersensitivity to paroxetine or to any of the inactive ingredients in PARIZ ER.
Bipolar Disorder: A major depressive episode may be the initial presentation of bipolar disorder.
Serotonin Syndrome: The development of a potentially life-threatening serotonin syndrome is linked with SNRIs and SSRIs, including PARIZ, alone but particularly with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. John's Wort) and with drugs that impair metabolism of serotonin (in particular, MAOIs, both those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).
This Medicine should not be use in Pregnancy.
It should not be used along with eliglustat, isocarboxazid, phenelzine, pimozide, procarbazine, selegiline, thioridazine and tranylcypromine.